Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brenda M Sandmaier

Showing results (11-20 of 296) with videos related to

Pageof 30
Sort By:
Hematology. American Society of Hematology. Education Program|November 25, 2006
Outcomes with myeloid malignanciesBart L Scott, Brenda M Sandmaier
Technology in Cancer Research & Treatment|July 21, 2005
Targeted cancer therapy using radiolabeled monoclonal antibodiesWolfgang A Bethge, Brenda M Sandmaier
Current Opinion in Hematology|October 10, 2013
Allogeneic hematopoietic cell transplantation for indolent non-Hodgkin lymphoma: indications and outcomesAndrew R Rezvani, Brenda M Sandmaier
Chimerism|July 10, 2012
Conditioning with α-emitter based radioimmunotherapy in canine allogeneic hematopoietic cell transplantationBrian Kornblit, Yun Chen, Brenda M Sandmaier
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 16, 2007
Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: current perspectivesBrenda M Sandmaier, Stephen Mackinnon, Richard W Childs
Frontiers in Oncology|July 8, 2026
Radioimmunotherapy as a targeted strategy of reduced-intensity conditioning for allogeneic transplantation in leukemiaPhuong T Vo, Johnnie J Orozco, Brenda M Sandmaier
Leukemia & Lymphoma|August 23, 2006
Radioimmunotherapy as non-myeloablative conditioning for allogeneic marrow transplantationWolfgang A Bethge, D Scott Wilbur, Brenda M Sandmaier
Clinical Breast Cancer|March 7, 2003
The role of cancer vaccines following autologous stem cell rescue in breast and ovarian cancer patients: experience with the STn-KLH vaccine (Theratope)Leona A Holmberg, Dimitri V Oparin, Ted Gooley, et al.
Frontiers in Immunology|June 11, 2026
Case Report: donor cell-derived leukemia after allogeneic stem cell transplantation for metastatic renal cell carcinomaFederico Monaco, Danh T Tran, Brenda M Sandmaier, et al.
Hematology. American Society of Hematology. Education Program|November 26, 2002
Non-myeloablative transplantationDavid G Maloney, Brenda M Sandmaier, Stephen Mackinnon, et al.
Pageof 30

Showing results (11-20 of 296) with videos related to

Sort By:
Pageof 30
Hematology. American Society of Hematology. Education Program|November 25, 2006
Outcomes with myeloid malignanciesBart L Scott, Brenda M Sandmaier
Technology in Cancer Research & Treatment|July 21, 2005
Targeted cancer therapy using radiolabeled monoclonal antibodiesWolfgang A Bethge, Brenda M Sandmaier
Current Opinion in Hematology|October 10, 2013
Allogeneic hematopoietic cell transplantation for indolent non-Hodgkin lymphoma: indications and outcomesAndrew R Rezvani, Brenda M Sandmaier
Chimerism|July 10, 2012
Conditioning with α-emitter based radioimmunotherapy in canine allogeneic hematopoietic cell transplantationBrian Kornblit, Yun Chen, Brenda M Sandmaier
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 16, 2007
Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: current perspectivesBrenda M Sandmaier, Stephen Mackinnon, Richard W Childs
Frontiers in Oncology|July 8, 2026
Radioimmunotherapy as a targeted strategy of reduced-intensity conditioning for allogeneic transplantation in leukemiaPhuong T Vo, Johnnie J Orozco, Brenda M Sandmaier
Leukemia & Lymphoma|August 23, 2006
Radioimmunotherapy as non-myeloablative conditioning for allogeneic marrow transplantationWolfgang A Bethge, D Scott Wilbur, Brenda M Sandmaier
Clinical Breast Cancer|March 7, 2003
The role of cancer vaccines following autologous stem cell rescue in breast and ovarian cancer patients: experience with the STn-KLH vaccine (Theratope)Leona A Holmberg, Dimitri V Oparin, Ted Gooley, et al.
Frontiers in Immunology|June 11, 2026
Case Report: donor cell-derived leukemia after allogeneic stem cell transplantation for metastatic renal cell carcinomaFederico Monaco, Danh T Tran, Brenda M Sandmaier, et al.
Hematology. American Society of Hematology. Education Program|November 26, 2002
Non-myeloablative transplantationDavid G Maloney, Brenda M Sandmaier, Stephen Mackinnon, et al.
Pageof 30